Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Gallstone
open-in-new
<h2 id="definition">Definition</h2> <p>Gallstone disease refers to the condition where gallstones are either in the gallbladder or common bile duct.<a class="footnote-ref" id="fnref:30" href="#fn:30"><sup>30</sup></a> The presence of stones in the gallbladder is referred to as <i>cholelithiasis</i>, from the Greek <i>chole-</i> (χολή, 'bile') + <i>lith-</i> (λίθος, 'stone') + <i>-iasis</i> (ἴασις, 'process').<a class="footnote-ref" id="fnref:31" href="#fn:31"><sup>31</sup></a> The presence of gallstones in the <a href="/facts/Common_bile_duct/9TsYu0sc">common bile duct</a> is called <i><a href="/facts/Choledocholithiasis/2hWEJbJU">choledocholithiasis</a></i>, from the Greek <i>choledocho-</i> (χοληδόχος, 'bile-containing', from <i>chol-</i> + <i>docho-</i>, 'duct') + <i>lith-</i> + <i>-iasis</i>.<a class="footnote-ref" id="fnref:32" href="#fn:32"><sup>32</sup></a> Choledocholithiasis is frequently associated with obstruction of the bile ducts, which can lead to <i><a href="/facts/Ascending_cholangitis/37cKJUB4">cholangitis</a></i>, from the Greek: <i>chol-</i> + <i>ang-</i> (ἄγγος, 'vessel') + <i>-itis</i> (-ῖτις, 'inflammation'), a serious infection of the bile ducts. Gallstones within the <a href="/facts/Ampulla_of_Vater/YBduX0We">ampulla of Vater</a> can obstruct the <a href="/facts/Exocrine_gland/svLWvb83">exocrine</a> system of the <a href="/facts/Pancreas/r0WPGjAq">pancreas</a> and can result in <a href="/facts/Pancreatitis/gmbNTcCG">pancreatitis</a>. </p> <h2 id="signs-and-symptoms">Signs and symptoms</h2> <p>Gallstones, regardless of size or number, are asymptomatic in 60-80% of patients.<a class="footnote-ref" id="fnref:33" href="#fn:33"><sup>33</sup></a><a class="footnote-ref" id="fnref:34" href="#fn:34"><sup>34</sup></a> These "silent stones" do not require treatment and can remain asymptomatic even years after they form. </p><h3>Biliary colic</h3> <p>Biliary <a href="/facts/Colic/xMrsSYHS">colic</a>, also known as symptomatic cholelithiasis, is what patients consider to be a "<a href="/facts/Biliary_colic/vVIlzhBl">gallstone attack</a>."<a class="footnote-ref" id="fnref:35" href="#fn:35"><sup>35</sup></a> These attacks occur when a gallstone blocks the opening to the cystic duct or the cystic duct itself, increasing the pressure inside the gallbladder as it contracts, which leads to pain.<a class="footnote-ref" id="fnref:36" href="#fn:36"><sup>36</sup></a> Patients typically experience sudden, severe pain in the right upper side of their abdomen or in the <a href="/facts/Epigastrium/USauNfqu">epigastric</a> area (the upper, center part of the abdomen). This pain typically peaks approximately 1 hour after the onset and usually subsides completely within 5 hours.<a class="footnote-ref" id="fnref:37" href="#fn:37"><sup>37</sup></a><a class="footnote-ref" id="fnref:38" href="#fn:38"><sup>38</sup></a> Sometimes, the pain may be referred to the right shoulder; this is called "Collin's sign".<a class="footnote-ref" id="fnref:39" href="#fn:39"><sup>39</sup></a> Patients may also experience nausea and vomiting. These attacks often occur after eating a fatty meal or at night.<a class="footnote-ref" id="fnref:40" href="#fn:40"><sup>40</sup></a><a class="footnote-ref" id="fnref:41" href="#fn:41"><sup>41</sup></a> Of note, laboratory studies of <a href="/facts/Liver_function_tests/IGuSa6Hn">AST, ALT</a>, alkaline phosphatase, direct <a href="/facts/Bilirubin/HCHyCjkt">bilirubin</a>, amylase, lipase, and <a href="/facts/White_blood_cell_count/NF9lNJL3">white blood cell</a> count are normal.<a class="footnote-ref" id="fnref:42" href="#fn:42"><sup>42</sup></a><a class="footnote-ref" id="fnref:43" href="#fn:43"><sup>43</sup></a> </p> <h3>Complications</h3> <h4>Acute Cholecystitis</h4> <p>Acute cholecystitis, or inflammation of the gallbladder, is caused by gallstones in 90-95% of cases.<a class="footnote-ref" id="fnref:44" href="#fn:44"><sup>44</sup></a> It presents very similarly to biliary colic: a sudden onset of severe pain in the right upper side of the abdomen or epigastric area.<a class="footnote-ref" id="fnref:45" href="#fn:45"><sup>45</sup></a> However, this pain differs from a gallstone attack because it lasts more than 6 hours and does not subside like a normal attack would.<a class="footnote-ref" id="fnref:46" href="#fn:46"><sup>46</sup></a><a class="footnote-ref" id="fnref:47" href="#fn:47"><sup>47</sup></a> In addition, patients also experience fever, decreased appetite, nausea, and vomiting. <a class="footnote-ref" id="fnref:48" href="#fn:48"><sup>48</sup></a><a class="footnote-ref" id="fnref:49" href="#fn:49"><sup>49</sup></a> On physical exam, the patient can have an increased temperature, <a href="/facts/Tachycardia/ycmyzP7q">tachycardia</a> (fast heart rate greater than 100 beats per minute), tenderness in the right upper quadrant (RUQ) of the abdomen, and a positive <a href="/facts/Murphy%2527s_sign/93WnNAFG">Murphy's sign</a>. Murphy's sign, which is specific for acute cholecystitis, is the sudden stoppage of inspiration when deep pressure is applied to the RUQ.<a class="footnote-ref" id="fnref:50" href="#fn:50"><sup>50</sup></a> Laboratory studies typically show a moderately increased white blood cell count and normal to slightly elevated AST, ALT, alkaline phosphatase, and direct bilirubin.<a class="footnote-ref" id="fnref:51" href="#fn:51"><sup>51</sup></a><a class="footnote-ref" id="fnref:52" href="#fn:52"><sup>52</sup></a> </p> <h4>Choledocholithiasis</h4> <p>Choledocholithiasis refers to a gallstone obstructing the <a href="/facts/Common_bile_duct/9TsYu0sc">common bile duct</a>.<a class="footnote-ref" id="fnref:53" href="#fn:53"><sup>53</sup></a> Patients typically experience right upper quadrant pain, back pain, <a href="/facts/Jaundice/TCyoLMJU">jaundice</a> (or yellowing of the skin), decreased appetite, nausea, vomiting, and/or fever.<a class="footnote-ref" id="fnref:54" href="#fn:54"><sup>54</sup></a><a class="footnote-ref" id="fnref:55" href="#fn:55"><sup>55</sup></a> However, choledocholithiasis, just like gallstones, can also be asymptomatic.<a class="footnote-ref" id="fnref:56" href="#fn:56"><sup>56</sup></a><a class="footnote-ref" id="fnref:57" href="#fn:57"><sup>57</sup></a> If the patient has symptoms, the physical exam is similar to that of acute cholecystitis. <a class="footnote-ref" id="fnref:58" href="#fn:58"><sup>58</sup></a> Laboratory studies show an increase in direct (conjugated) bilirubin, gamma-glutamyl transpeptidase (GGT), and alkaline phosphatase. AST and ALT can be elevated or normal.<a class="footnote-ref" id="fnref:59" href="#fn:59"><sup>59</sup></a><a class="footnote-ref" id="fnref:60" href="#fn:60"><sup>60</sup></a><a class="footnote-ref" id="fnref:61" href="#fn:61"><sup>61</sup></a> </p> <h4>Ascending Cholangitis</h4> <p>Ascending cholangitis is a complication of choledocholithiasis. When a gallstone obstructs the common bile duct, inflammation and infection of the biliary tree can occur.<a class="footnote-ref" id="fnref:62" href="#fn:62"><sup>62</sup></a><a class="footnote-ref" id="fnref:63" href="#fn:63"><sup>63</sup></a> Approximately 2/3 of patients present with the classic <a href="/facts/Charcot%2527s_triad/AYqmBYq3">Charcot's triad</a>: jaundice, fever or chills, and right upper quadrant pain.<a class="footnote-ref" id="fnref:64" href="#fn:64"><sup>64</sup></a><a class="footnote-ref" id="fnref:65" href="#fn:65"><sup>65</sup></a> This can progress to septic shock, which presents as <a href="/facts/Reynolds%2527_pentad/KXkTxJzq">Reynold's pentad</a> (Charcot's triad plus hypotension and altered mental status).<a class="footnote-ref" id="fnref:66" href="#fn:66"><sup>66</sup></a> Laboratory studies show an increase in white blood cell count, direct bilirubin, alkaline phosphatase, AST, and ALT.<a class="footnote-ref" id="fnref:67" href="#fn:67"><sup>67</sup></a> </p> <h4>Gallstone (Biliary) Pancreatitis</h4> <p>Pancreatitis is the inflammation of the pancreas. Gallstone pancreatitis occurs when a gallstone slips down the biliary tree and gets stuck in either the <a href="/facts/Pancreatic_duct/tLKRDmSE">pancreatic duct</a> or at the <a href="/facts/Ampulla_of_Vater/YBduX0We">ampulla of Vater</a>.<a class="footnote-ref" id="fnref:68" href="#fn:68"><sup>68</sup></a><a class="footnote-ref" id="fnref:69" href="#fn:69"><sup>69</sup></a> Gallstone pancreatitis presents the same as acute pancreatitis: a sudden onset of epigastric pain that moves towards the back, decrease in appetite, nausea, and vomiting. Laboratory studies will show an elevated lipase, amylase, and white blood cell count.<a class="footnote-ref" id="fnref:70" href="#fn:70"><sup>70</sup></a><a class="footnote-ref" id="fnref:71" href="#fn:71"><sup>71</sup></a> </p> <h4>Gallstone Ileus</h4> <p>Large gallstones can potentially erode through the gallbladder wall and into the neighboring small intestine. This large stone then travels through the small intestine until it is too narrow for the stone to continue, causing a <a href="/facts/Bowel_obstruction/RG1bIVss">small bowel obstruction.</a> This obstruction often occurs at previous surgical sites or at the <a href="/facts/Ileocecal_valve/gFp1QLwa">ileocecal valve</a> (the portion of the bowel where the small intestine meets the large intestine). The patient presents with the inability to defecate or pass gas, nausea, vomiting, and severe abdominal pain.<a class="footnote-ref" id="fnref:72" href="#fn:72"><sup>72</sup></a> </p> <h4>Cancer</h4> <p>Rarely, <a href="/facts/Gallbladder_cancer/sDfkTUgc">gallbladder cancer</a> may occur as a complication in the setting of chronic gallstones.<a class="footnote-ref" id="fnref:73" href="#fn:73"><sup>73</sup></a> </p> <h2 id="risk-factors">Risk factors</h2> <p>Gallstone risk increases for females (especially before menopause) and for people near or above 40 years;<a class="footnote-ref" id="fnref:74" href="#fn:74"><sup>74</sup></a> the condition is more prevalent among people of European or American Indigenous descent than among other ethnicities.<a class="footnote-ref" id="fnref:75" href="#fn:75"><sup>75</sup></a> A lack of <a href="/facts/Melatonin/LEyEWg18">melatonin</a> could significantly contribute to gallbladder stones, as melatonin inhibits cholesterol secretion from the gallbladder, enhances the conversion of cholesterol to bile, and is an antioxidant, which is able to reduce oxidative stress to the gallbladder.<a class="footnote-ref" id="fnref:76" href="#fn:76"><sup>76</sup></a> <a href="/facts/Gilbert%2527s_syndrome/mc4xzBbB">Gilbert syndrome</a> has been linked to an increased risk of gallstones.<a class="footnote-ref" id="fnref:77" href="#fn:77"><sup>77</sup></a> Researchers believe that gallstones may be caused by a combination of factors, including inherited body chemistry, <a href="/facts/Human_weight/QWW2LqSw">body weight</a>, gallbladder <a href="/facts/Motility/Df5BECHL">motility</a> (movement), and low-calorie diet.<a class="footnote-ref" id="fnref:78" href="#fn:78"><sup>78</sup></a> The absence of such risk factors does not, however, preclude the formation of gallstones. </p><p>Nutritional factors that may increase risk of gallstones include <a href="/facts/Constipation/l4DHHM6L">constipation</a>; eating fewer meals per day; low intake of the nutrients <a href="/facts/Folic_acid/8Eb7An6D">folate</a>, <a href="/facts/Magnesium/XyIhd2FG">magnesium</a>, <a href="/facts/Calcium/hf252CC0">calcium</a>, and <a href="/facts/Vitamin_C/IA2f1fTm">vitamin C</a>;<a class="footnote-ref" id="fnref:79" href="#fn:79"><sup>79</sup></a> low fluid consumption;<a class="footnote-ref" id="fnref:80" href="#fn:80"><sup>80</sup></a> and, at least for men, a high intake of <a href="/facts/Carbohydrate/Geuuzxsf">carbohydrate</a>, a high <a href="/facts/Glycemic_load/Pt7nbTeo">glycemic load</a>, and high <a href="/facts/Glycemic_index/LD57X1KR">glycemic index</a> diet.<a class="footnote-ref" id="fnref:81" href="#fn:81"><sup>81</sup></a> Wine and whole-grained bread may decrease the risk of gallstones.<a class="footnote-ref" id="fnref:82" href="#fn:82"><sup>82</sup></a> </p><p>Rapid weight loss increases risk of gallstones.<a class="footnote-ref" id="fnref:83" href="#fn:83"><sup>83</sup></a> The weight loss drug <a href="/facts/Orlistat/eWGDHFWp">orlistat</a> is known to increase the risk of gallstones.<a class="footnote-ref" id="fnref:84" href="#fn:84"><sup>84</sup></a> </p><p>Cholecystokinin deficiency caused by <a href="/facts/Celiac_disease/AKd5PkTc">celiac disease</a> increases risk of gallstone formation, especially when diagnosis of celiac disease is delayed.<a class="footnote-ref" id="fnref:85" href="#fn:85"><sup>85</sup></a> </p><p>Pigment gallstones are most commonly seen in the developing world. Risk factors for pigment stones include <a href="/facts/Hemolytic_anemia/qNz6wDct">hemolytic anemias</a> (such as from <a href="/facts/Sickle-cell_disease/93LT7ATq">sickle-cell disease</a> and <a href="/facts/Hereditary_spherocytosis/e3WwHaAn">hereditary spherocytosis</a>), <a href="/facts/Cirrhosis/bkLuLvCD">cirrhosis</a>, and biliary tract infections.<a class="footnote-ref" id="fnref:86" href="#fn:86"><sup>86</sup></a> People with <a href="/facts/Erythropoietic_protoporphyria/xWg32hpT">erythropoietic protoporphyria</a> (EPP) are at increased risk to develop gallstones.<a class="footnote-ref" id="fnref:87" href="#fn:87"><sup>87</sup></a><a class="footnote-ref" id="fnref:88" href="#fn:88"><sup>88</sup></a> Additionally, prolonged use of <a href="/facts/Proton_pump_inhibitors/JIpwabbk">proton pump inhibitors</a> has been shown to decrease gallbladder function, potentially leading to gallstone formation.<a class="footnote-ref" id="fnref:89" href="#fn:89"><sup>89</sup></a> </p><p>Cholesterol modifying medications can affect gallstone formation. <a href="/facts/Statin/ba4mes9W">Statins</a> inhibit cholesterol synthesis and there is evidence that their use may decrease the risk of getting gallstones.<a class="footnote-ref" id="fnref:90" href="#fn:90"><sup>90</sup></a><a class="footnote-ref" id="fnref:91" href="#fn:91"><sup>91</sup></a> <a href="/facts/Fibrate/IuI8Dqjd">Fibrates</a> increase cholesterol concentration in bile and their use has been associated with an increased risk of gallstones.<a class="footnote-ref" id="fnref:92" href="#fn:92"><sup>92</sup></a> <a href="/facts/Bile_acid_malabsorption/IPyeu2Nb">Bile acid malabsorption</a> may also be a risk. </p> <h2 id="pathophysiology">Pathophysiology</h2> <p>Cholesterol gallstones develop when bile contains too much cholesterol and not enough <a href="/facts/Bile_acid/ojTJzf0c">bile salts</a>. Besides a high concentration of cholesterol, two other factors are important in causing gallstones. The first is how often and how well the gallbladder contracts; incomplete and infrequent emptying of the gallbladder may cause the bile to become overconcentrated and contribute to gallstone formation. This can be caused by high resistance to the flow of bile out of the gallbladder due to the complicated internal geometry of the cystic duct.<a class="footnote-ref" id="fnref:93" href="#fn:93"><sup>93</sup></a> The second factor is the presence of proteins in the liver and bile that either promote or inhibit cholesterol crystallization into gallstones. In addition, increased levels of the hormone <a href="/facts/Estrogen/dPEewnDV">estrogen</a>, as a result of <a href="/facts/Pregnancy/vEKYGpep">pregnancy</a> or <a href="/facts/Hormone_therapy/8QNWRguk">hormone therapy</a>, or the use of combined (estrogen-containing) forms of <a href="/facts/Hormonal_contraception/xVw5DPGT">hormonal contraception</a>, may increase cholesterol levels in bile and also decrease gallbladder motility, resulting in gallstone formation. </p> <h3>Composition</h3> <p>The composition of gallstones is affected by age, diet and <a href="/facts/Ethnic_group/XSp5l24t">ethnicity</a>.<a class="footnote-ref" id="fnref:94" href="#fn:94"><sup>94</sup></a> On the basis of their composition, gallstones can be divided into the following types: cholesterol stones, pigment stones, and mixed stones.<a class="footnote-ref" id="fnref:95" href="#fn:95"><sup>95</sup></a> An ideal classification system is yet to be defined.<a class="footnote-ref" id="fnref:96" href="#fn:96"><sup>96</sup></a> </p> <h4>Cholesterol stones</h4> <p><a href="/facts/Cholesterol/TnfPlYc1">Cholesterol</a> stones vary from light yellow to dark green or brown or chalk white and are oval, usually solitary, between 2 and 3 cm long, each often having a tiny, dark, central spot. To be classified as such, they must be at least 80% cholesterol by weight (or 70%, according to the Japanese classification system).<a class="footnote-ref" id="fnref:97" href="#fn:97"><sup>97</sup></a> Between 35% and 90% of stones are cholesterol stones.<a class="footnote-ref" id="fnref:98" href="#fn:98"><sup>98</sup></a> </p> <h4>Pigment stones</h4> <p><a href="/facts/Bilirubin/HCHyCjkt">Bilirubin</a> ("pigment", "black pigment") stones are small, dark (often appearing black), and usually numerous. They are composed primarily of bilirubin (insoluble bilirubin pigment polymer) and <a href="/facts/Calcium/hf252CC0">calcium</a> (calcium phosphate) <a href="/facts/Salt_(chemistry)/lsSKwGpn">salts</a> that are found in bile. They contain less than 20% of cholesterol (or 30%, according to the Japanese classification system).<a class="footnote-ref" id="fnref:99" href="#fn:99"><sup>99</sup></a> Between 2% and 30% of stones are bilirubin stones.<a class="footnote-ref" id="fnref:100" href="#fn:100"><sup>100</sup></a> </p> <h4>Mixed stones</h4> <p>Mixed (<a href="/facts/Stercobilin/mLkQfB66">brown pigment</a> stones) typically contain 20–80% cholesterol (or 30–70%, according to the Japanese classification system).<a class="footnote-ref" id="fnref:101" href="#fn:101"><sup>101</sup></a> Other common constituents are <a href="/facts/Calcium_carbonate/UQ1wLFna">calcium carbonate</a>, <a href="/facts/Palmitate/wPvdsPHA">palmitate</a> phosphate, bilirubin and other <a href="/facts/Bilin_(biochemistry)/KogFByqU">bile pigments</a> (calcium bilirubinate, calcium palmitate and <a href="/facts/Calcium_stearate/phdADnKN">calcium stearate</a>). Because of their calcium content, they are often <a href="/facts/Radiolucent/TakP45NW">radiographically visible</a>. They typically arise secondary to infection of the biliary tract which results in the release of <a href="/facts/%25CE%2592-glucuronidase/ctR23pbs">β-glucuronidase</a> (by injured <a href="/facts/Hepatocyte/USpvDz1n">hepatocytes</a> and bacteria) which hydrolyzes bilirubin <a href="/facts/Glucuronide/I1EMKqWM">glucuronides</a> and increases the amount of unconjugated bilirubin in bile. Between 4% and 20% of stones are mixed.<a class="footnote-ref" id="fnref:102" href="#fn:102"><sup>102</sup></a> </p><p>Gallstones can vary in size and shape from as small as a grain of sand to as large as a golf ball.<a class="footnote-ref" id="fnref:103" href="#fn:103"><sup>103</sup></a> The gallbladder may contain a single large stone or many smaller ones. Pseudoliths, sometimes referred to as sludge, are thick <a href="/facts/Secretion/VHk9eLAV">secretions</a> that may be present within the gallbladder, either alone or in conjunction with fully formed gallstones. </p> <h2 id="diagnosis">Diagnosis</h2> <p>Diagnosis is typically confirmed by <a href="/facts/Abdominal_ultrasound/tLjP82VP">abdominal ultrasound</a>. Other imaging techniques used are <a href="/facts/ERCP/BpfeWhVP">ERCP</a> and <a href="/facts/Magnetic_resonance_cholangiopancreatography/kFzSD3jh">MRCP</a>. Gallstone complications may be detected on blood tests.<a class="footnote-ref" id="fnref:104" href="#fn:104"><sup>104</sup></a> </p><p>On abdominal ultrasound, sinking gallstones usually have posterior acoustic shadowing. In floating gallstones, reverberation echoes (or comet-tail artifact) is seen instead in a clinical condition called <a href="/facts/Adenomyomatosis/1h6lohwA">adenomyomatosis</a>. Another sign is wall-echo-shadow (WES) triad (or double-arc shadow) which is also characteristic of gallstones.<a class="footnote-ref" id="fnref:105" href="#fn:105"><sup>105</sup></a> </p><p>A positive <a href="/facts/Murphy%2527s_sign/93WnNAFG">Murphy's sign</a> is a common finding on <a href="/facts/Physical_examination/qzI0BK5P">physical examination</a> during a gallbladder attack. </p> <h2 id="prevention">Prevention</h2> <p>Maintaining a healthy weight by getting sufficient exercise and eating a <a href="/facts/Healthy_diet/sjJBXc4l">healthy diet</a> that is high in <a href="/facts/Dietary_fiber/Q9DXanDv">fiber</a> may help prevent gallstone formation.<a class="footnote-ref" id="fnref:106" href="#fn:106"><sup>106</sup></a> </p><p><a href="/facts/Ursodeoxycholic_acid/855WSxHT">Ursodeoxycholic acid</a> (UDCA) appears to prevent formation of gallstones during weight loss. A high fat diet during weight loss also appears to prevent gallstones.<a class="footnote-ref" id="fnref:107" href="#fn:107"><sup>107</sup></a> </p> <h2 id="treatment">Treatment</h2> <h3>Lithotripsy</h3> <p><a href="/facts/Extracorporeal_shockwave_therapy/z5yz9hlp">Extracorporeal shock wave lithotripsy</a> is a non-invasive method to manage gallstones that uses high-energy sound waves to disintegrate them first applied in January 1985.<a class="footnote-ref" id="fnref:108" href="#fn:108"><sup>108</sup></a><a class="footnote-ref" id="fnref:109" href="#fn:109"><sup>109</sup></a> Side effects of extracorporeal shock wave lithotripsy include biliary pancreatitis and liver haematoma.<a class="footnote-ref" id="fnref:110" href="#fn:110"><sup>110</sup></a> The term is derived from the Greek words meaning 'breaking (or pulverizing) stones': <i>litho-</i> + τρίψω, <i>tripso</i>). </p> <h3>Surgical</h3> <p><a href="/facts/Cholecystectomy/petQE34t">Cholecystectomy</a> (gallbladder removal) has a 99% chance of eliminating the recurrence of cholelithiasis. The lack of a gallbladder has no negative consequences in most people, however 10 to 15% of people develop <a href="/facts/Postcholecystectomy_syndrome/XvNvDQrj">postcholecystectomy syndrome</a>,<a class="footnote-ref" id="fnref:111" href="#fn:111"><sup>111</sup></a> which may cause nausea, indigestion, diarrhea, and episodes of abdominal pain.<a class="footnote-ref" id="fnref:112" href="#fn:112"><sup>112</sup></a> </p> <p>There are two surgical options for cholecystectomy: </p> <ul><li>Open cholecystectomy is performed via an abdominal incision (<a href="/facts/Laparotomy/JqKMjJ41">laparotomy</a>) below the lower right ribs. Recovery typically requires 3–5 days of hospitalization, with a return to normal diet a week after release and to normal activity several weeks after release.<a class="footnote-ref" id="fnref:113" href="#fn:113"><sup>113</sup></a></li> <li><a href="/facts/Laparoscopy/cTMKggTn">Laparoscopic</a> cholecystectomy, introduced in the 1980s, is performed via three to four small puncture holes for a camera and instruments. Post-operative care typically includes a same-day release or a one-night hospital stay, followed by a few days of home rest and pain medication.<a class="footnote-ref" id="fnref:114" href="#fn:114"><sup>114</sup></a> Perforation of the gall bladder is not uncommon—it has been reported in the range of 10% to 40%. Unretrieved gallstone spillage has been reported as 6% to 30%, but gallstones that are not retrieved rarely cause complications (0.08%–0.3%).<a class="footnote-ref" id="fnref:115" href="#fn:115"><sup>115</sup></a></li></ul> <p>Obstruction of the common bile duct with gallstones can sometimes be relieved by endoscopic retrograde sphincterotomy (ERS) following <a href="/facts/Endoscopic_retrograde_cholangiopancreatography/BpfeWhVP">endoscopic retrograde cholangiopancreatography</a> (ERCP).<a class="footnote-ref" id="fnref:116" href="#fn:116"><sup>116</sup></a> </p> <p>Surgery carries risks and some people continue to experience symptoms (including pain) afterwards, for reasons that remain unclear. An alternative option is to adopt a ‘watch and wait’ strategy before operating to see if symptoms resolve. A study compared the 2 approaches for uncomplicated gallstones and after 18 months, both approaches were associated with similar levels of pain. The watch and wait approach was also less costly (more than £1000 less per patient).<a class="footnote-ref" id="fnref:117" href="#fn:117"><sup>117</sup></a><a class="footnote-ref" id="fnref:118" href="#fn:118"><sup>118</sup></a> </p><h3>Medical</h3> <p>The medications <a href="/facts/Ursodeoxycholic_acid/855WSxHT">ursodeoxycholic acid</a> (UDCA) and <a href="/facts/Chenodeoxycholic_acid/lUBLponl">chenodeoxycholic acid</a> (CDCA) have been used in treatment to dissolve gallstones.<a class="footnote-ref" id="fnref:119" href="#fn:119"><sup>119</sup></a><a class="footnote-ref" id="fnref:120" href="#fn:120"><sup>120</sup></a> A 2013 meta-analysis concluded that UDCA or higher dietary fat content appeared to prevent formation of gallstones during weight loss.<a class="footnote-ref" id="fnref:121" href="#fn:121"><sup>121</sup></a> Medical therapy with oral bile acids has been used to treat small cholesterol stones, and for larger cholesterol gallstones when surgery is either not possible or unwanted. CDCA treatment can cause diarrhea, mild reversible hepatic injury, and a small increase in the plasma cholesterol level.<a class="footnote-ref" id="fnref:122" href="#fn:122"><sup>122</sup></a> UDCA may need to be taken for years.<a class="footnote-ref" id="fnref:123" href="#fn:123"><sup>123</sup></a> </p> <h2 id="use-in-alternative-medicine">Use in alternative medicine</h2> <p>Gallstones can be a valued by-product of animals butchered for meat because of their use as an <a href="/facts/Antipyretic/lBVzyUFN">antipyretic</a> and antidote in the <a href="/facts/Traditional_medicine/WLUmXCHz">traditional medicine</a> of some cultures, particularly <a href="/facts/Traditional_Chinese_medicine/51rSRXua">traditional Chinese medicine</a>. The most highly prized gallstones tend to be sourced from old <a href="/facts/Dairy_cattle/DqGHuSXU">dairy cows</a>, termed <a href="/facts/Calculus_bovis/QTt9e8GP">calculus bovis</a> or <i>niu-huang</i> (yellow thing of cattle) in Chinese. Some slaughterhouses carefully scrutinize workers for gallstone theft.<a class="footnote-ref" id="fnref:124" href="#fn:124"><sup>124</sup></a> </p> <h2 id="see-also">See also</h2> <ul><li><a href="/facts/Mirizzi%2527s_syndrome/fBSb9DhK">Mirizzi's syndrome</a></li> <li><a href="/facts/Porcelain_gallbladder/zN4E2FSu">Porcelain gallbladder</a></li></ul> <h2 id="external-links">External links</h2> Wikimedia Commons has media related to Gallstones. <ul><li><a href="https://medlineplus.gov/gallstones.html">"Gallstones"</a>. <a href="/facts/MedlinePlus/bl3BjdjK">MedlinePlus</a>. U.S. National Library of Medicine.</li></ul> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>Gallstone Disease: Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis. National Institute for Health and Care Excellence: Guidelines. National Institute for Health and Care Excellence (NICE). October 2014. p. 101. PMID 25473723. <a href="https://www.ncbi.nlm.nih.gov/books/NBK258747/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK258747/</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. (2016). "2016 WSES guidelines on acute calculous cholecystitis". World Journal of Emergency Surgery. 11: 25. doi:10.1186/s13017-016-0082-5. PMC 4908702. PMID 27307785. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> <li id="fn:6"><p>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. (2016). "2016 WSES guidelines on acute calculous cholecystitis". World Journal of Emergency Surgery. 11: 25. doi:10.1186/s13017-016-0082-5. PMC 4908702. PMID 27307785. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li> <li id="fn:7"><p>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. (2016). "2016 WSES guidelines on acute calculous cholecystitis". World Journal of Emergency Surgery. 11: 25. doi:10.1186/s13017-016-0082-5. PMC 4908702. PMID 27307785. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li> <li id="fn:8"><p>"Complications". nhs.uk. Retrieved 13 May 2018. <a href="https://www.nhs.uk/conditions/gallstones/complications/" target="_blank">https://www.nhs.uk/conditions/gallstones/complications/</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li> <li id="fn:9"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li> <li id="fn:10"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:10" class="footnote-back-ref">↩</a></p></li> <li id="fn:11"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:11" class="footnote-back-ref">↩</a></p></li> <li id="fn:12"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:12" class="footnote-back-ref">↩</a></p></li> <li id="fn:13"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:13" class="footnote-back-ref">↩</a></p></li> <li id="fn:14"><p>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. (2016). "2016 WSES guidelines on acute calculous cholecystitis". World Journal of Emergency Surgery. 11: 25. doi:10.1186/s13017-016-0082-5. PMC 4908702. PMID 27307785. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702</a> <a href="#fnref:14" class="footnote-back-ref">↩</a></p></li> <li id="fn:15"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:15" class="footnote-back-ref">↩</a></p></li> <li id="fn:16"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:16" class="footnote-back-ref">↩</a></p></li> <li id="fn:17"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:17" class="footnote-back-ref">↩</a></p></li> <li id="fn:18"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:18" class="footnote-back-ref">↩</a></p></li> <li id="fn:19"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:19" class="footnote-back-ref">↩</a></p></li> <li id="fn:20"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:20" class="footnote-back-ref">↩</a></p></li> <li id="fn:21"><p>"Treatment for Gallstones". National Institute of Diabetes and Digestive and Kidney Diseases. November 2017. <a href="https://www.niddk.nih.gov/health-information/digestive-diseases/gallstones/treatment" target="_blank">https://www.niddk.nih.gov/health-information/digestive-diseases/gallstones/treatment</a> <a href="#fnref:21" class="footnote-back-ref">↩</a></p></li> <li id="fn:22"><p>Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. (2016). "2016 WSES guidelines on acute calculous cholecystitis". World Journal of Emergency Surgery. 11: 25. doi:10.1186/s13017-016-0082-5. PMC 4908702. PMID 27307785. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908702</a> <a href="#fnref:22" class="footnote-back-ref">↩</a></p></li> <li id="fn:23"><p>Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561509" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561509</a> <a href="#fnref:23" class="footnote-back-ref">↩</a></p></li> <li id="fn:24"><p>"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. January 2015. doi:10.1016/s0140-6736(14)61682-2. PMC 4340604. PMID 25530442. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340604" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340604</a> <a href="#fnref:24" class="footnote-back-ref">↩</a></p></li> <li id="fn:25"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:25" class="footnote-back-ref">↩</a></p></li> <li id="fn:26"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:26" class="footnote-back-ref">↩</a></p></li> <li id="fn:27"><p>Rosenthal RA, Zenilman ME, Katlic MR, eds. (2011). Principles and practice of geriatric surgery (2nd ed.). Berlin: Springer. p. 944. ISBN 978-1-4419-6999-6. Archived from the original on 2016-08-15. <a href="978-1-4419-6999-6" target="_blank">978-1-4419-6999-6</a> <a href="#fnref:27" class="footnote-back-ref">↩</a></p></li> <li id="fn:28"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:28" class="footnote-back-ref">↩</a></p></li> <li id="fn:29"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:29" class="footnote-back-ref">↩</a></p></li> <li id="fn:30"><p>Gallstone Disease: Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis. National Institute for Health and Care Excellence: Guidelines. National Institute for Health and Care Excellence (NICE). October 2014. p. 101. PMID 25473723. <a href="https://www.ncbi.nlm.nih.gov/books/NBK258747/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK258747/</a> <a href="#fnref:30" class="footnote-back-ref">↩</a></p></li> <li id="fn:31"><p>Quick CR, Reed JB, Harper SJ, Saeb-Parsy K, Deakin PJ (2013). Essential Surgery E-Book: Problems, Diagnosis and Management: With student consult online access. Elsevier Health Sciences. p. 281. ISBN 978-0-7020-5483-9. <a href="978-0-7020-5483-9" target="_blank">978-0-7020-5483-9</a> <a href="#fnref:31" class="footnote-back-ref">↩</a></p></li> <li id="fn:32"><p>Quick CR, Reed JB, Harper SJ, Saeb-Parsy K, Deakin PJ (2013). Essential Surgery E-Book: Problems, Diagnosis and Management: With student consult online access. Elsevier Health Sciences. p. 281. ISBN 978-0-7020-5483-9. <a href="978-0-7020-5483-9" target="_blank">978-0-7020-5483-9</a> <a href="#fnref:32" class="footnote-back-ref">↩</a></p></li> <li id="fn:33"><p>Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, et al. (August 2003). "Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study". The American Journal of Gastroenterology. 98 (8): 1856–1860. doi:10.1111/j.1572-0241.2003.07618.x. ISSN 0002-9270. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:33" class="footnote-back-ref">↩</a></p></li> <li id="fn:34"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:34" class="footnote-back-ref">↩</a></p></li> <li id="fn:35"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:35" class="footnote-back-ref">↩</a></p></li> <li id="fn:36"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:36" class="footnote-back-ref">↩</a></p></li> <li id="fn:37"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:37" class="footnote-back-ref">↩</a></p></li> <li id="fn:38"><p>Patel H, Jepsen J (2024). "Gallstone Disease: Common Questions and Answers". Am Fam Physciian. 109 (6): 518–524. <a href="#fnref:38" class="footnote-back-ref">↩</a></p></li> <li id="fn:39"><p>Gilani SN, Bass G, Leader F, Walsh TN (December 2009). "Collins' sign: validation of a clinical sign in cholelithiasis". Irish Journal of Medical Science. 178 (4): 397–400. doi:10.1007/s11845-009-0404-7. ISSN 0021-1265. <a href="http://link.springer.com/10.1007/s11845-009-0404-7" target="_blank">http://link.springer.com/10.1007/s11845-009-0404-7</a> <a href="#fnref:39" class="footnote-back-ref">↩</a></p></li> <li id="fn:40"><p>Patel H, Jepsen J (2024). "Gallstone Disease: Common Questions and Answers". Am Fam Physciian. 109 (6): 518–524. <a href="#fnref:40" class="footnote-back-ref">↩</a></p></li> <li id="fn:41"><p>Doherty GM (2010). "Cholelithiasis". Quick Answers Surgery – via The McGraw-Hill Companies. <a href="#fnref:41" class="footnote-back-ref">↩</a></p></li> <li id="fn:42"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:42" class="footnote-back-ref">↩</a></p></li> <li id="fn:43"><p>Doherty GM (2010). "Cholelithiasis". Quick Answers Surgery – via The McGraw-Hill Companies. <a href="#fnref:43" class="footnote-back-ref">↩</a></p></li> <li id="fn:44"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:44" class="footnote-back-ref">↩</a></p></li> <li id="fn:45"><p>Patel H, Jepsen J (2024). "Gallstone Disease: Common Questions and Answers". Am Fam Physciian. 109 (6): 518–524. <a href="#fnref:45" class="footnote-back-ref">↩</a></p></li> <li id="fn:46"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:46" class="footnote-back-ref">↩</a></p></li> <li id="fn:47"><p>Patel H, Jepsen J (2024). "Gallstone Disease: Common Questions and Answers". Am Fam Physciian. 109 (6): 518–524. <a href="#fnref:47" class="footnote-back-ref">↩</a></p></li> <li id="fn:48"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:48" class="footnote-back-ref">↩</a></p></li> <li id="fn:49"><p>Jones MW, Weir CB, Ghassemzadeh S (2025), "Gallstones (Cholelithiasis)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29083691, retrieved 2025-04-24 <a href="https://www.ncbi.nlm.nih.gov/books/NBK459370/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK459370/</a> <a href="#fnref:49" class="footnote-back-ref">↩</a></p></li> <li id="fn:50"><p>Ahern G, Brygel M (2014). "Abdomen". Exploring Essential Surgery – via McGraw-Hill Education. <a href="https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265" target="_blank">https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265</a> <a href="#fnref:50" class="footnote-back-ref">↩</a></p></li> <li id="fn:51"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:51" class="footnote-back-ref">↩</a></p></li> <li id="fn:52"><p>Jones MW, Weir CB, Ghassemzadeh S (2025), "Gallstones (Cholelithiasis)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29083691, retrieved 2025-04-24 <a href="https://www.ncbi.nlm.nih.gov/books/NBK459370/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK459370/</a> <a href="#fnref:52" class="footnote-back-ref">↩</a></p></li> <li id="fn:53"><p>Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, et al. (September 2023). "Evidence-based clinical practice guidelines for cholelithiasis 2021". Journal of Gastroenterology. 58 (9): 801–833. doi:10.1007/s00535-023-02014-6. ISSN 0944-1174. PMC 10423145. PMID 37452855. <a href="https://link.springer.com/10.1007/s00535-023-02014-6" target="_blank">https://link.springer.com/10.1007/s00535-023-02014-6</a> <a href="#fnref:53" class="footnote-back-ref">↩</a></p></li> <li id="fn:54"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:54" class="footnote-back-ref">↩</a></p></li> <li id="fn:55"><p>Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, et al. (September 2023). "Evidence-based clinical practice guidelines for cholelithiasis 2021". Journal of Gastroenterology. 58 (9): 801–833. doi:10.1007/s00535-023-02014-6. ISSN 0944-1174. PMC 10423145. PMID 37452855. <a href="https://link.springer.com/10.1007/s00535-023-02014-6" target="_blank">https://link.springer.com/10.1007/s00535-023-02014-6</a> <a href="#fnref:55" class="footnote-back-ref">↩</a></p></li> <li id="fn:56"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:56" class="footnote-back-ref">↩</a></p></li> <li id="fn:57"><p>Doherty GM (2010). "Choledocholithiasis & Gallstone Pancreatitis". Quick Answers Surgery – via The McGraw-Hill Companies. <a href="#fnref:57" class="footnote-back-ref">↩</a></p></li> <li id="fn:58"><p>Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, et al. (September 2023). "Evidence-based clinical practice guidelines for cholelithiasis 2021". Journal of Gastroenterology. 58 (9): 801–833. doi:10.1007/s00535-023-02014-6. ISSN 0944-1174. PMC 10423145. PMID 37452855. <a href="https://link.springer.com/10.1007/s00535-023-02014-6" target="_blank">https://link.springer.com/10.1007/s00535-023-02014-6</a> <a href="#fnref:58" class="footnote-back-ref">↩</a></p></li> <li id="fn:59"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:59" class="footnote-back-ref">↩</a></p></li> <li id="fn:60"><p>Patel H, Jepsen J (2024). "Gallstone Disease: Common Questions and Answers". Am Fam Physciian. 109 (6): 518–524. <a href="#fnref:60" class="footnote-back-ref">↩</a></p></li> <li id="fn:61"><p>Doherty GM (2010). "Choledocholithiasis & Gallstone Pancreatitis". Quick Answers Surgery – via The McGraw-Hill Companies. <a href="#fnref:61" class="footnote-back-ref">↩</a></p></li> <li id="fn:62"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:62" class="footnote-back-ref">↩</a></p></li> <li id="fn:63"><p>Ahern G, Brygel M (2014). "Abdomen". Exploring Essential Surgery – via McGraw-Hill Education. <a href="https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265" target="_blank">https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265</a> <a href="#fnref:63" class="footnote-back-ref">↩</a></p></li> <li id="fn:64"><p>Lammert F, Wittenburg H (August 2024). "Gallstones: Prevention, Diagnosis, and Treatment". Seminars in Liver Disease. 44 (03): 394–404. doi:10.1055/a-2378-9025. ISSN 0272-8087. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025" target="_blank">http://www.thieme-connect.de/DOI/DOI?10.1055/a-2378-9025</a> <a href="#fnref:64" class="footnote-back-ref">↩</a></p></li> <li id="fn:65"><p>Ahern G, Brygel M (2014). "Abdomen". Exploring Essential Surgery – via McGraw-Hill Education. <a href="https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265" target="_blank">https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265</a> <a href="#fnref:65" class="footnote-back-ref">↩</a></p></li> <li id="fn:66"><p>Jones MW, Weir CB, Ghassemzadeh S (2025), "Gallstones (Cholelithiasis)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29083691, retrieved 2025-04-24 <a href="https://www.ncbi.nlm.nih.gov/books/NBK459370/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK459370/</a> <a href="#fnref:66" class="footnote-back-ref">↩</a></p></li> <li id="fn:67"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:67" class="footnote-back-ref">↩</a></p></li> <li id="fn:68"><p>Jones MW, Weir CB, Ghassemzadeh S (2025), "Gallstones (Cholelithiasis)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29083691, retrieved 2025-04-24 <a href="https://www.ncbi.nlm.nih.gov/books/NBK459370/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK459370/</a> <a href="#fnref:68" class="footnote-back-ref">↩</a></p></li> <li id="fn:69"><p>Ahern G, Brygel M (2014). "Abdomen". Exploring Essential Surgery – via McGraw-Hill Education. <a href="https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265" target="_blank">https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265</a> <a href="#fnref:69" class="footnote-back-ref">↩</a></p></li> <li id="fn:70"><p>Ahern G, Brygel M (2014). "Abdomen". Exploring Essential Surgery – via McGraw-Hill Education. <a href="https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265" target="_blank">https://accesssurgery-mhmedical-com/content.aspx?bookid=2740§ionid=232638265</a> <a href="#fnref:70" class="footnote-back-ref">↩</a></p></li> <li id="fn:71"><p>Doherty GM (2010). "Choledocholithiasis & Gallstone Pancreatitis". Quick Answers Surgery – via The McGraw-Hill Companies. <a href="#fnref:71" class="footnote-back-ref">↩</a></p></li> <li id="fn:72"><p>Haisley KR, Hunter JG (2019). "Gallbladder and the Extrahepatic Biliary System". Schwartz's Principles of Surgery, 11e – via McGraw-Hill Education. <a href="#fnref:72" class="footnote-back-ref">↩</a></p></li> <li id="fn:73"><p>"Complications". nhs.uk. Retrieved 13 May 2018. <a href="https://www.nhs.uk/conditions/gallstones/complications/" target="_blank">https://www.nhs.uk/conditions/gallstones/complications/</a> <a href="#fnref:73" class="footnote-back-ref">↩</a></p></li> <li id="fn:74"><p>Roizen MF, Oz MC (2005). Gut Feelings: Your Digestive System. Pymble, NSW: HarperCollins e-books. pp. 175–206. ISBN 978-0-06-198079-4. <a href="978-0-06-198079-4" target="_blank">978-0-06-198079-4</a> <a href="#fnref:74" class="footnote-back-ref">↩</a></p></li> <li id="fn:75"><p>Afdhal N, Zakko S (Sep 2022). "Gallstones: Epidemiology, risk factors and prevention". UpToDate. Retrieved 2023-05-26. <a href="https://www.uptodate.com/contents/gallstones-epidemiology-risk-factors-and-prevention" target="_blank">https://www.uptodate.com/contents/gallstones-epidemiology-risk-factors-and-prevention</a> <a href="#fnref:75" class="footnote-back-ref">↩</a></p></li> <li id="fn:76"><p>Koppisetti S, Jenigiri B, Terron MP, Tengattini S, Tamura H, Flores LJ, et al. (October 2008). "Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review". Digestive Diseases and Sciences. 53 (10): 2592–603. doi:10.1007/s10620-007-0195-5. PMID 18338264. S2CID 22785223. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:76" class="footnote-back-ref">↩</a></p></li> <li id="fn:77"><p>del Giudice EM, Perrotta S, Nobili B, Specchia C, d'Urzo G, Iolascon A (October 1999). "Coinheritance of Gilbert Syndrome Increases the Risk for Developing Gallstones in Patients With Hereditary Spherocytosis" (PDF). Blood. 94 (7): 2259–2262. doi:10.1182/blood.V94.7.2259.419k42_2259_2262. PMID 10498597. S2CID 40558696. <a href="http://ashpublications.org/blood/article-pdf/94/7/2259/1658539/2259.pdf" target="_blank">http://ashpublications.org/blood/article-pdf/94/7/2259/1658539/2259.pdf</a> <a href="#fnref:77" class="footnote-back-ref">↩</a></p></li> <li id="fn:78"><p>Afdhal N, Zakko S (Sep 2022). "Gallstones: Epidemiology, risk factors and prevention". UpToDate. Retrieved 2023-05-26. <a href="https://www.uptodate.com/contents/gallstones-epidemiology-risk-factors-and-prevention" target="_blank">https://www.uptodate.com/contents/gallstones-epidemiology-risk-factors-and-prevention</a> <a href="#fnref:78" class="footnote-back-ref">↩</a></p></li> <li id="fn:79"><p>Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, Andrés P, López-Sobaler AM (February 1997). "Differences in diet and food habits between patients with gallstones and controls". Journal of the American College of Nutrition. 16 (1): 88–95. doi:10.1080/07315724.1997.10718655. PMID 9013440. Archived from the original on 2008-07-20. Retrieved 2010-11-06. <a href="https://web.archive.org/web/20080720125626/http://www.jacn.org/cgi/content/abstract/16/1/88" target="_blank">https://web.archive.org/web/20080720125626/http://www.jacn.org/cgi/content/abstract/16/1/88</a> <a href="#fnref:79" class="footnote-back-ref">↩</a></p></li> <li id="fn:80"><p>Institute of Medicine, Food Nutrition Board, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Panel on Dietary Reference Intakes for Electrolytes and Water (2005). 4 Water | Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. The National Academies Press. p. 124. doi:10.17226/10925. ISBN 978-0-309-09169-5. <a href="978-0-309-09169-5" target="_blank">978-0-309-09169-5</a> <a href="#fnref:80" class="footnote-back-ref">↩</a></p></li> <li id="fn:81"><p>Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (June 2005). "Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men". Gut. 54 (6): 823–8. doi:10.1136/gut.2003.031435. PMC 1774557. PMID 15888792. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774557" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774557</a> <a href="#fnref:81" class="footnote-back-ref">↩</a></p></li> <li id="fn:82"><p>Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, et al. (June 1996). "Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors". European Journal of Gastroenterology & Hepatology. 8 (6): 585–93. doi:10.1097/00042737-199606000-00017. PMID 8823575. S2CID 11355563. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:82" class="footnote-back-ref">↩</a></p></li> <li id="fn:83"><p>NHS Choices. "Should you lose weight fast? – Live Well—NHS Choices". www.nhs.uk. Archived from the original on 2016-02-16. Retrieved 2016-02-16. <a href="http://www.nhs.uk/Livewell/loseweight/Pages/should-you-lose-weight-fast.aspx" target="_blank">http://www.nhs.uk/Livewell/loseweight/Pages/should-you-lose-weight-fast.aspx</a> <a href="#fnref:83" class="footnote-back-ref">↩</a></p></li> <li id="fn:84"><p>Office of the Commissioner. "Safety Information—Xenical (orlistat) capsules". www.fda.gov. Archived from the original on 2016-06-11. Retrieved 2016-06-18. <a href="https://web.archive.org/web/20160611084534/https://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm215504.htm" target="_blank">https://web.archive.org/web/20160611084534/https://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm215504.htm</a> <a href="#fnref:84" class="footnote-back-ref">↩</a></p></li> <li id="fn:85"><p>Wang HH, Liu M, Li X, Portincasa P, Wang DQ (April 2017). "Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease". European Journal of Clinical Investigation (Review). 47 (4): 328–333. doi:10.1111/eci.12734. PMC 8135131. PMID 28186337. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135131" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135131</a> <a href="#fnref:85" class="footnote-back-ref">↩</a></p></li> <li id="fn:86"><p>Trotman BW, Bernstein SE, Bove KE, Wirt GD (June 1980). "Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model". The Journal of Clinical Investigation. 65 (6): 1301–8. doi:10.1172/JCI109793. PMC 371467. PMID 7410545. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371467" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371467</a> <a href="#fnref:86" class="footnote-back-ref">↩</a></p></li> <li id="fn:87"><p>Endocrine and Metabolic Disorders: Cutaneous Porphyrias, pp. 63–220 in Beers, Porter and Jones (2006) <a href="#fnref:87" class="footnote-back-ref">↩</a></p></li> <li id="fn:88"><p>Thunell S (2008). "Endocrine and Metabolic Disorders: Cutaneous Porphyrias". Whitehouse Station, New Jersey: Merck Sharp & Dohme Corporation. Archived from the original on 2020-03-12. Retrieved 2010-11-07. <a href="https://web.archive.org/web/20200312142747/http://www.merck.com/mmpe/sec12/ch155/ch155c.html?qt=Erythropoietic%20Protoporphyria&alt=sh#sec12-ch155-ch155c-635" target="_blank">https://web.archive.org/web/20200312142747/http://www.merck.com/mmpe/sec12/ch155/ch155c.html?qt=Erythropoietic%20Protoporphyria&alt=sh#sec12-ch155-ch155c-635</a> <a href="#fnref:88" class="footnote-back-ref">↩</a></p></li> <li id="fn:89"><p>Cahan MA, Balduf L, Colton K, Palacioz B, McCartney W, Farrell TM (September 2006). "Proton pump inhibitors reduce gallbladder function". Surgical Endoscopy. 20 (9): 1364–7. doi:10.1007/s00464-005-0247-x. PMID 16858534. S2CID 20833380. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:89" class="footnote-back-ref">↩</a></p></li> <li id="fn:90"><p>Kan HP, Guo WB, Tan YF, Zhou J, Liu CD, Huang YQ (September 2015). "Statin use and risk of gallstone disease: A meta-analysis". Hepatology Research. 45 (9): 942–948. doi:10.1111/hepr.12433. PMID 25297889. S2CID 25636425. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:90" class="footnote-back-ref">↩</a></p></li> <li id="fn:91"><p>Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, et al. (August 2012). "Lipid-modifying therapies and risk of pancreatitis: a meta-analysis" (PDF). JAMA. 308 (8): 804–11. doi:10.1001/jama.2012.8439. PMID 22910758. <a href="http://eprints.gla.ac.uk/69063/3/69063.pdf" target="_blank">http://eprints.gla.ac.uk/69063/3/69063.pdf</a> <a href="#fnref:91" class="footnote-back-ref">↩</a></p></li> <li id="fn:92"><p>Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, et al. (August 2012). "Lipid-modifying therapies and risk of pancreatitis: a meta-analysis" (PDF). JAMA. 308 (8): 804–11. doi:10.1001/jama.2012.8439. PMID 22910758. <a href="http://eprints.gla.ac.uk/69063/3/69063.pdf" target="_blank">http://eprints.gla.ac.uk/69063/3/69063.pdf</a> <a href="#fnref:92" class="footnote-back-ref">↩</a></p></li> <li id="fn:93"><p>Experimental investigation of the flow of bile in patient specific cystic duct models M Al-Atabi, SB Chin..., Journal of biomechanical engineering, 2010 <a href="#fnref:93" class="footnote-back-ref">↩</a></p></li> <li id="fn:94"><p>Channa NA, Khand FD, Khand TU, Leghari MH, Memon AN (2007). "Analysis of human gallstones by Fourier Transform Infrared (FTIR)". Pakistan Journal of Medical Sciences. 23 (4): 546–50. Archived from the original on 2011-08-24. Retrieved 2010-11-06. <a href="http://pjms.com.pk/issues/julsep07/article/article15.html" target="_blank">http://pjms.com.pk/issues/julsep07/article/article15.html</a> <a href="#fnref:94" class="footnote-back-ref">↩</a></p></li> <li id="fn:95"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:95" class="footnote-back-ref">↩</a></p></li> <li id="fn:96"><p>Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH (August 2003). "Classification and nomenclature of gallstones revisited". Yonsei Medical Journal. 44 (4): 561–70. doi:10.3349/ymj.2003.44.4.561. PMID 12950109. <a href="https://doi.org/10.3349%2Fymj.2003.44.4.561" target="_blank">https://doi.org/10.3349%2Fymj.2003.44.4.561</a> <a href="#fnref:96" class="footnote-back-ref">↩</a></p></li> <li id="fn:97"><p>Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH (August 2003). "Classification and nomenclature of gallstones revisited". Yonsei Medical Journal. 44 (4): 561–70. doi:10.3349/ymj.2003.44.4.561. PMID 12950109. <a href="https://doi.org/10.3349%2Fymj.2003.44.4.561" target="_blank">https://doi.org/10.3349%2Fymj.2003.44.4.561</a> <a href="#fnref:97" class="footnote-back-ref">↩</a></p></li> <li id="fn:98"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:98" class="footnote-back-ref">↩</a></p></li> <li id="fn:99"><p>Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH (August 2003). "Classification and nomenclature of gallstones revisited". Yonsei Medical Journal. 44 (4): 561–70. doi:10.3349/ymj.2003.44.4.561. PMID 12950109. <a href="https://doi.org/10.3349%2Fymj.2003.44.4.561" target="_blank">https://doi.org/10.3349%2Fymj.2003.44.4.561</a> <a href="#fnref:99" class="footnote-back-ref">↩</a></p></li> <li id="fn:100"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:100" class="footnote-back-ref">↩</a></p></li> <li id="fn:101"><p>Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH (August 2003). "Classification and nomenclature of gallstones revisited". Yonsei Medical Journal. 44 (4): 561–70. doi:10.3349/ymj.2003.44.4.561. PMID 12950109. <a href="https://doi.org/10.3349%2Fymj.2003.44.4.561" target="_blank">https://doi.org/10.3349%2Fymj.2003.44.4.561</a> <a href="#fnref:101" class="footnote-back-ref">↩</a></p></li> <li id="fn:102"><p>Lee JY, Keane MG, Pereira S (June 2015). "Diagnosis and treatment of gallstone disease". The Practitioner. 259 (1783): 15–9, 2. PMID 26455113. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:102" class="footnote-back-ref">↩</a></p></li> <li id="fn:103"><p>Gallstones—Cholelithiasis; Gallbladder attack; Biliary colic; Gallstone attack; Bile calculus; Biliary calculus Archived 2011-02-07 at the Wayback Machine Last reviewed: July 6, 2009. Reviewed by: George F. Longstreth. Also reviewed by David Zieve <a href="https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001318" target="_blank">https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001318</a> <a href="#fnref:103" class="footnote-back-ref">↩</a></p></li> <li id="fn:104"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:104" class="footnote-back-ref">↩</a></p></li> <li id="fn:105"><p>Fitzgerald EJ, Toi A (July 1987). "Pitfalls in the ultrasonographic diagnosis of gallbladder diseases". Postgraduate Medical Journal. 63 (741): 525–32. doi:10.1136/pgmj.63.741.525. PMC 2428351. PMID 3309915. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2428351" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2428351</a> <a href="#fnref:105" class="footnote-back-ref">↩</a></p></li> <li id="fn:106"><p>"Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016. <a href="https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx" target="_blank">https://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/gallstones/Pages/facts.aspx</a> <a href="#fnref:106" class="footnote-back-ref">↩</a></p></li> <li id="fn:107"><p>Stokes CS, Gluud LL, Casper M, Lammert F (July 2014). "Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials". Clinical Gastroenterology and Hepatology. 12 (7): 1090–1100.e2, quiz e61. doi:10.1016/j.cgh.2013.11.031. PMID 24321208. <a href="https://doi.org/10.1016%2Fj.cgh.2013.11.031" target="_blank">https://doi.org/10.1016%2Fj.cgh.2013.11.031</a> <a href="#fnref:107" class="footnote-back-ref">↩</a></p></li> <li id="fn:108"><p>"Gallstone Disease Treatment". Johns Hopkins Medicine. Retrieved 2021-09-25. <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/gallstone-disease-treatment" target="_blank">https://www.hopkinsmedicine.org/health/conditions-and-diseases/gallstone-disease-treatment</a> <a href="#fnref:108" class="footnote-back-ref">↩</a></p></li> <li id="fn:109"><p>Paumgartner G, Sauter GH (May 2005). "Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment". European Journal of Gastroenterology & Hepatology. 17 (5): 525–527. doi:10.1097/00042737-200505000-00009. PMID 15827443. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:109" class="footnote-back-ref">↩</a></p></li> <li id="fn:110"><p>Paumgartner G, Sauter GH (May 2005). "Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment". European Journal of Gastroenterology & Hepatology. 17 (5): 525–527. doi:10.1097/00042737-200505000-00009. PMID 15827443. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:110" class="footnote-back-ref">↩</a></p></li> <li id="fn:111"><p>Jensen (2010). "Postcholecystectomy syndrome". Omaha, Nebraska: Medscape (WebMD). Archived from the original on 2010-12-23. Retrieved 2011-01-20. <a href="http://emedicine.medscape.com/article/192761-overview" target="_blank">http://emedicine.medscape.com/article/192761-overview</a> <a href="#fnref:111" class="footnote-back-ref">↩</a></p></li> <li id="fn:112"><p>Zackria R, Lopez RA (January 2019). "Postcholecystectomy Syndrome". StatPearls. PMID 30969724. <a href="/wiki/PMID_(identifier)" target="_blank">/wiki/PMID_(identifier)</a> <a href="#fnref:112" class="footnote-back-ref">↩</a></p></li> <li id="fn:113"><p>National Institute of Diabetes and Digestive and Kidney Diseases (2007). "Gallstones" (PDF). Bethesda, Maryland: National Digestive Diseases Information Clearinghouse, National Institutes of Health, United States Department of Health and Human Services. Archived from the original (PDF) on 2010-12-05. Retrieved 2010-11-06. <a href="/wiki/National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases" target="_blank">/wiki/National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases</a> <a href="#fnref:113" class="footnote-back-ref">↩</a></p></li> <li id="fn:114"><p>National Institute of Diabetes and Digestive and Kidney Diseases (2007). "Gallstones" (PDF). Bethesda, Maryland: National Digestive Diseases Information Clearinghouse, National Institutes of Health, United States Department of Health and Human Services. Archived from the original (PDF) on 2010-12-05. Retrieved 2010-11-06. <a href="/wiki/National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases" target="_blank">/wiki/National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases</a> <a href="#fnref:114" class="footnote-back-ref">↩</a></p></li> <li id="fn:115"><p>Sathesh-Kumar T, Saklani AP, Vinayagam R, Blackett RL (17 February 2004). "Spilled gall stones during laparoscopic cholecystectomy: a review of the literature". Postgraduate Medical Journal. 80 (940): 77–79. doi:10.1136/pmj.2003.006023. PMC 1742934. PMID 14970293. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1742934" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1742934</a> <a href="#fnref:115" class="footnote-back-ref">↩</a></p></li> <li id="fn:116"><p>National Health Service (2010). "Gallstones — Treatment". NHS Choices: Health A-Z—Conditions and treatments. London: National Health Service. Archived from the original on 2010-11-14. Retrieved 2010-11-06. <a href="/wiki/National_Health_Service_(England)" target="_blank">/wiki/National_Health_Service_(England)</a> <a href="#fnref:116" class="footnote-back-ref">↩</a></p></li> <li id="fn:117"><p>Ahmed I, Hudson J, Innes K, Hernández R, Gillies K, Bruce R, et al. (2023-12-06). "Effectiveness of conservative management versus laparoscopic cholecystectomy in the prevention of recurrent symptoms and complications in adults with uncomplicated symptomatic gallstone disease (C-GALL trial): pragmatic, multicentre randomised controlled trial". BMJ. 383: e075383. doi:10.1136/bmj-2023-075383. ISSN 1756-1833. PMC 10698555. PMID 38084426. <a href="https://www.bmj.com/content/383/bmj-2023-075383" target="_blank">https://www.bmj.com/content/383/bmj-2023-075383</a> <a href="#fnref:117" class="footnote-back-ref">↩</a></p></li> <li id="fn:118"><p>"Gallstones: surgery might not always be needed". NIHR Evidence. 31 October 2024. <a href="https://evidence.nihr.ac.uk/alert/gallstones-surgery-might-not-always-be-needed/" target="_blank">https://evidence.nihr.ac.uk/alert/gallstones-surgery-might-not-always-be-needed/</a> <a href="#fnref:118" class="footnote-back-ref">↩</a></p></li> <li id="fn:119"><p>Thistle JL, Hofmann AF (September 1973). "Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones". The New England Journal of Medicine. 289 (13): 655–9. doi:10.1056/NEJM197309272891303. PMID 4580472. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:119" class="footnote-back-ref">↩</a></p></li> <li id="fn:120"><p>Hofmann AF (September 1989). "Medical dissolution of gallstones by oral bile acid therapy". American Journal of Surgery. 158 (3): 198–204. doi:10.1016/0002-9610(89)90252-3. PMID 2672842. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:120" class="footnote-back-ref">↩</a></p></li> <li id="fn:121"><p>Stokes CS, Gluud LL, Casper M, Lammert F (July 2014). "Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials". Clinical Gastroenterology and Hepatology. 12 (7): 1090–1100.e2, quiz e61. doi:10.1016/j.cgh.2013.11.031. PMID 24321208. <a href="https://doi.org/10.1016%2Fj.cgh.2013.11.031" target="_blank">https://doi.org/10.1016%2Fj.cgh.2013.11.031</a> <a href="#fnref:121" class="footnote-back-ref">↩</a></p></li> <li id="fn:122"><p>Hofmann AF (September 1989). "Medical dissolution of gallstones by oral bile acid therapy". American Journal of Surgery. 158 (3): 198–204. doi:10.1016/0002-9610(89)90252-3. PMID 2672842. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:122" class="footnote-back-ref">↩</a></p></li> <li id="fn:123"><p>National Health Service (2010). "Gallstones — Treatment". NHS Choices: Health A-Z—Conditions and treatments. London: National Health Service. Archived from the original on 2010-11-14. Retrieved 2010-11-06. <a href="/wiki/National_Health_Service_(England)" target="_blank">/wiki/National_Health_Service_(England)</a> <a href="#fnref:123" class="footnote-back-ref">↩</a></p></li> <li id="fn:124"><p>"Interview with Darren Wise. Transcrip". Omaha, Nebraska: Medscape (WebMD). Archived from the original on 2010-11-21. Retrieved 2010-11-06. <a href="https://web.archive.org/web/20101121121630/http://sgp1.paddington.ninemsn.com.au/sunday/cover_stories/transcript_785.asp" target="_blank">https://web.archive.org/web/20101121121630/http://sgp1.paddington.ninemsn.com.au/sunday/cover_stories/transcript_785.asp</a> <a href="#fnref:124" class="footnote-back-ref">↩</a></p></li> </ol>